Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypertension in chronic kidney disease: What lies behind the scene
Omar Z. Ameer
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Risk Factors of Chronic Kidney Disease Progression: Between Old and New Concepts
Francesca Mallamaci, Giovanni Tripepi
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 678-678
Open Access | Times Cited: 32
Renal-Protective Roles of Lipoic Acid in Kidney Disease
Sulin F. Kamt, Jiankang Liu, Liang‐Jun Yan
Nutrients (2023) Vol. 15, Iss. 7, pp. 1732-1732
Open Access | Times Cited: 24
The Role of the Vascular System in Degenerative Diseases: Mechanisms and Implications
Abdullah Md. Sheikh, Shozo Yano, Shatera Tabassum, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2169-2169
Open Access | Times Cited: 11
Beneficial Effects of Butyrate on Kidney Disease
Tram N. Diep, Haoxin Liu, Liang‐Jun Yan
Nutrients (2025) Vol. 17, Iss. 5, pp. 772-772
Open Access | Times Cited: 1
Mechanisms of inflammation modulation by different immune cells in hypertensive nephropathy
Hao Xiaomin, Yu Liu, Dilizhawaer Hailaiti, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Deliverables from Metabolomics in Kidney Disease: Adenine, New Insights, and Implication for Clinical Decision-Making
Nagarjunachary Ragi, Kumar Sharma
American Journal of Nephrology (2024) Vol. 55, Iss. 4, pp. 421-438
Open Access | Times Cited: 6
Mineralocorticoid receptors contribute to ethanol-induced vascular hypercontractility through reactive oxygen species generation and up-regulation of cyclooxygenase 2
Thales M. H. Dourado, Victor O. Assis, Wanessa M.C. Awata, et al.
European Journal of Pharmacology (2023) Vol. 949, pp. 175723-175723
Closed Access | Times Cited: 12
Phytopharmaceutical and innovative nanocarriers for chronic kidney diseases: a comprehensive review
M. Keerthana Devi, B. Sajeev Kumar
Discover Plants. (2025) Vol. 2, Iss. 1
Open Access
Comparative Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers in Hypertensive Patients With Chronic Kidney Disease: A Systematic Review
Mouzafar A Mhmndar, Taranpreet Singh, Iram Fatima, et al.
Cureus (2025)
Open Access
Assessment of Potentially Nephrotoxic Drug Prescriptions in Chronic Kidney Disease Outpatients at a Hospital in Indonesia
Larasati Arrum Kusumawardani, Hindun Wilda Risni, Darisa Naurahhanan, et al.
International Journal of Nephrology and Renovascular Disease (2025) Vol. Volume 18, pp. 59-69
Open Access
Prolonged Hospital Stay in Hypertensive Patients: Retrospective Analysis of Risk Factors and Interactions
Stanisław Surma, Michał Czapla, Izabella Uchmanowicz, et al.
Nursing Reports (2025) Vol. 15, Iss. 3, pp. 110-110
Open Access
CKD as a Cause of Hypertension in Children and Adolescents
Empar Lurbe
Updates in hypertension and cardiovascular protection (2025), pp. 147-159
Closed Access
Treatment of Hypertension in Chronic Kidney Disease
Josep Redón
Updates in hypertension and cardiovascular protection (2025), pp. 329-347
Closed Access
Association between dietary inflammatory index and risk of chronic kidney disease and low glomerular filtration rate; a systematic review and meta-analysis of observational studies
Amirhossein Ataei Kachouei, Frazam Kamrani, Neda Akhavan, et al.
Journal of Health Population and Nutrition (2025) Vol. 44, Iss. 1
Open Access
Construction of a risk prediction model for hypertension in type 2 diabetes: Independent risk factors and nomogram
Jianyong Zhao, Jing-ting Dou, Mingwei Chen
World Journal of Diabetes (2025) Vol. 16, Iss. 5
Closed Access
The relative potential contribution of volume load and vascular mechanisms to hypertension in non-dialysis and dialysis chronic kidney disease patients
Grace Tade, Hon‐Chun Hsu, Chanel Robinson, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Causes of Chronic Kidney Disease and Their Associations with Cardiovascular Risk and Disease in a Sub-Saharan Low-Income Population
Nkosingiphile Twala, Grace Tade, Patrick H Dessein, et al.
International Journal of Nephrology and Renovascular Disease (2024) Vol. Volume 17, pp. 175-195
Open Access | Times Cited: 2
The importance of paraoxonase 1 activity in chronic kidney disease
Elisabeth C. Samouilidou, Augustina Liaouri, V. Kostopoulos, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 2
Advances in CRISPR-Cas systems for kidney diseases
Bhupendra Puri, Yogesh A. Kulkarni, Anil Bhanudas Gaikwad
Progress in molecular biology and translational science (2024), pp. 149-162
Closed Access | Times Cited: 2
Unraveling the Mechanisms of Magnesium Supplementation in Alleviating Chronic Kidney Disease Complications and Progression: Balancing Risks and Benefits
Majid Sadeghpour, Ali Bejani, Maryam Hosseini Kupaei, et al.
Biological Trace Element Research (2024)
Closed Access | Times Cited: 2
Machine learning applications in healthcare clinical practice and research
Nikolaos‐Achilleas Arkoudis, Stavros P. Papadakos
World Journal of Clinical Cases (2024) Vol. 13, Iss. 1
Closed Access | Times Cited: 2
Gut Microbiota and Gut–Brain Axis in Hypertension: Implications for Kidney and Cardiovascular Health—A Narrative Review
Ewelina Młynarska, Jakub Wasiak, Agata Gajewska, et al.
Nutrients (2024) Vol. 16, Iss. 23, pp. 4079-4079
Open Access | Times Cited: 2
Differential central integration of left versus right baroreceptor afferent input in spontaneously hypertensive rats
Ibrahim M. Salman, Omar Z. Ameer, Sheridan McMurray, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 7, pp. 1191-1200
Open Access | Times Cited: 5
Drug repurposing screens to identify potential drugs for chronic kidney disease by targeting prostaglandin E2 receptor
Hung-Jin Huang, Yu‐Hsuan Lee, Li‐Chin Sung, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 3490-3502
Open Access | Times Cited: 5
The Role of Ketone Bodies in Various Animal Models of Kidney Disease
Haoxin Liu, Liang‐Jun Yan
Endocrines (2023) Vol. 4, Iss. 1, pp. 236-249
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top